Lipoprotein oxidation, antioxidants and cardiovascular risk: epidemiologic evidence

被引:40
作者
vandeVijver, LPL
Kardinaal, AFM
Grobbee, DE
Princen, HMG
vanPoppel, G
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT EPIDEMIOL & BIOSTAT, NL-3000 DR ROTTERDAM, NETHERLANDS
[2] UNIV UTRECHT, JULIUS CTR PATIENT ORIENTED RES, UTRECHT, NETHERLANDS
[3] UNIV UTRECHT, SCH MED, NL-3584 CX UTRECHT, NETHERLANDS
[4] TNO, PG, GAUBIUS LAB, LEIDEN, NETHERLANDS
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1997年 / 57卷 / 4-5期
关键词
D O I
10.1016/S0952-3278(97)90432-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review summarizes the scientific evidence for a possible role of antioxidants in the prevention of coronary heart disease (CHD). Dietary antioxidants include vitamin E, vitamin C and beta-carotene, whereas selenium is an integral part of the antioxidant enzyme glutathione peroxidase. Experimental studies suggest that the oxidation of low-density lipoproteins (LDL) in the vessel wall plays an important role in the development of atherosclerotic lesions. The resistance of LDL to oxidation is increased by antioxidant supplementation, at least in vitro. Epidemiological studies have not demonstrated unequivocally that a high intake of antioxidants leads to a decreased risk of CHD. Studies on dietary intake and serum levels of antioxidants do point in the direction of a preventive effect of antioxidants, whereas the results of intervention studies are less conclusive. Beta-carotene supplementation is not associated with any decrease in CHD; high doses of vitamin E may be beneficial, but results from large trials are to be awaited, General preventive measures based on antioxidant supplementation are not yet justifiable.
引用
收藏
页码:479 / 487
页数:9
相关论文
共 88 条
[81]  
VERLANGIERI AJ, 1992, J AM COLL NUTR, V11, P131
[82]   ANTI-OXIDIZED LOW-DENSITY-LIPOPROTEIN ANTIBODIES IN PATIENTS WITH CORONARY HEART-DISEASE AND NORMAL HEALTHY-VOLUNTEERS [J].
VIRELLA, G ;
VIRELLA, I ;
LEMAN, RB ;
PRYOR, MB ;
LOPESVIRELLA, MF .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1993, 23 (02) :95-101
[83]   SERUM SELENIUM AND THE RISK OF CORONARY HEART-DISEASE AND STROKE [J].
VIRTAMO, J ;
VALKEILA, E ;
ALFTHAN, G ;
PUNSAR, S ;
HUTTUNEN, JK ;
KARVONEN, MJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 122 (02) :276-282
[84]   THE EFFECT OF PROBUCOL ON FEMORAL ATHEROSCLEROSIS - THE PROBUCOL QUANTITATIVE REGRESSION SWEDISH TRIAL (PQRST) [J].
WALLDIUS, G ;
ERIKSON, U ;
OLSSON, AG ;
BERGSTRAND, L ;
HADELL, K ;
JOHANSSON, J ;
KAIJSER, L ;
LASSVIK, C ;
MOLGAARD, J ;
NILSSON, S ;
SCHAFERELINDER, L ;
STENPORT, G ;
HOLME, I .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (09) :875-883
[85]   DIETARY VITAMIN-E AND THE ATTENUATION OF EARLY LESION DEVELOPMENT IN MODIFIED WATANABE RABBITS [J].
WILLIAMS, RJ ;
MOTTERAM, JM ;
SHARP, CH ;
GALLAGHER, PJ .
ATHEROSCLEROSIS, 1992, 94 (2-3) :153-159
[86]   THE EFFECTS OF HIGH-LEVELS OF VITAMIN-E ON THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].
WILLINGHAM, AK ;
BOLANOS, C ;
BOHANNAN, E ;
CENEDELLA, RJ .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1993, 4 (11) :651-654
[87]   ROLE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN ATHEROGENESIS [J].
WITZTUM, JL ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1785-1792
[88]   EFFECT OF SELENIUM AND VITAMIN-E ON THE DEVELOPMENT OF EXPERIMENTAL ATHEROSCLEROSIS IN RABBITS [J].
WOJCICKI, J ;
ROZEWICKA, L ;
BARCEWWISZNIEWSKA, B ;
SAMOCHOWIEC, L ;
JUZWIAK, S ;
KADLUBOWSKA, D ;
TUSTANOWSKI, S ;
JUZYSZYN, Z .
ATHEROSCLEROSIS, 1991, 87 (01) :9-16